Leading stocks in today’s market: Mylan N.V. (NASDAQ:MYL)

With its market value over its outstanding shares, Mylan N.V. (NASDAQ:MYL) Drugs – Generic has a market capitalization valued at Drugs – Generic. As the outstanding stock of Mylan N.V. NASDAQ:MYL Drugs – Generic is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of Mylan N.V. MYL Drugs – Generic. The existing figure surely determines the key factor in some forms of the stocks valuation. The present market cap reflects only on the equity of NASDAQ:MYL Drugs – Generic and is vital to note that the firm’s choice of capital structure holds a substantial impact on how the aggregate value of the company allocated within the equity and debt.

Mylan N.V. (NASDAQ:MYL) Drugs – Generic has a Price Earning Ratio of 76.84, which in return shows a value of 7.35 on the Forward PE Ratio. The current PEG for Mylan N.V. NASDAQ:MYL is valued at 8.68 with a P/S value of 2.03.

Mylan N.V. (NASDAQ:MYL) Drugs – Generic prevailing Dividend Yield is *TBA that has a Payout Ratio of 0.00%. The firm has an EPS value of 0.51, resultantly displaying an EPS growth for this year at -31.50%. Mylan N.V. MYL measures an EPS growth for 2017 at a rate of 12.42% that consequently shows an EPS growth of 20.20% for the past five years, and an EPS growth of 8.86% for the following five years.

Return on Assets (ROA) for Mylan N.V. NASDAQ:MYL Drugs – Generic is currently valued at 0.90%. Company’s Return on Investment (ROI) shows a figure of 8.20%. The Current Ratio of Mylan N.V. NASDAQ:MYL Drugs – Generic is 0.8 and the Quick Ratio measures to be 0.6. The Long Term Debt/Equity is valued 0.96 with the Total Debt/Equity of 1.34.

Mylan N.V. (NASDAQ:MYL) Drugs – Generic exhibits an Operating Margin of 8.00% and a Gross Margin of 43.60%, therefore, displaying a Profit Margin of 2.50%. The 20-Day Simple Moving Average is determined at 5.08% that showed a 200-Day Simple Moving Average of -4.11%.

The current Stock Price for Mylan N.V. (NASDAQ:MYL) Drugs – Generic is 39.31 with a change in price of 0.31%. Mylan N.V. MYL showed a Day High of -2.46% in today’s Market that also showed a Day Low of 16.34%. Its 52-Week High was -24.01% and 52-Week Low was 16.99%.

Disclaimer:  Outlined statistics and information communicated in the above editorial are merely a work of the authors. They do not ponder or echo the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Specimens laid down on the editorial above are only cases with information collected from various sources. The authority will not be liable for anyone who makes stock portfolio or financial decisions as per the editorial, which is based only on limited and open source. 

Share This Post

Post Comment